• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 4. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 5. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aniline and substituted anilines

Chemical Profile of 1-(3-Aminophenyl)-3-methyl-1H-pyrazol-5(4H)-one (CAS No. 90-32-4)

1-(3-Aminophenyl)-3-methyl-1H-pyrazol-5(4H)-one, identified by its CAS number 90-32-4, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the pyrazole class, a scaffold that is widely recognized for its biological activity and structural versatility. The presence of both an amino group and a methyl substituent on the pyrazole ring enhances its potential as a pharmacophore, making it a valuable candidate for further exploration in drug discovery.

The 1-(3-Aminophenyl)-3-methyl-1H-pyrazol-5(4H)-one structure combines the electron-donating properties of the amino group with the steric and electronic effects of the methyl group, which can influence its interactions with biological targets. This dual functionality has been exploited in various synthetic strategies to develop derivatives with enhanced potency and selectivity. The compound’s aromaticity and conjugation contribute to its stability and solubility, which are critical factors in pharmaceutical formulations.

In recent years, there has been a surge in research focused on developing novel therapeutic agents derived from pyrazole derivatives. The 1-(3-Aminophenyl)-3-methyl-1H-pyrazol-5(4H)-one scaffold has been particularly studied for its potential applications in treating inflammatory diseases, neurological disorders, and even certain types of cancer. Its ability to modulate enzyme activity and receptor binding has made it a promising candidate for further preclinical and clinical investigations.

One of the most compelling aspects of 1-(3-Aminophenyl)-3-methyl-1H-pyrazol-5(4H)-one is its role as a key intermediate in synthesizing more complex molecules. Researchers have leveraged this compound to develop libraries of derivatives that exhibit diverse biological activities. For instance, modifications at the 3-position of the pyrazole ring have been shown to enhance binding affinity to specific protein targets, while alterations at the 5-position can influence metabolic stability.

The pharmacokinetic properties of 1-(3-Aminophenyl)-3-methyl-1H-pyrazol-5(4H)-one are also of great interest. Studies have indicated that this compound exhibits moderate oral bioavailability and favorable distribution characteristics, suggesting its potential for systemic administration. Additionally, its chemical stability under various conditions makes it suitable for formulation into tablets, capsules, or other dosage forms.

From a synthetic chemistry perspective, 1-(3-Aminophenyl)-3-methyl-1H-pyrazol-5(4H)-one serves as a versatile building block for constructing more intricate molecular architectures. The presence of both an amino group and a methyl group provides multiple sites for functionalization, allowing chemists to tailor the compound’s properties to specific therapeutic needs. This flexibility has led to the development of several novel analogs with improved pharmacological profiles.

The growing body of literature on 1-(3-Aminophenyl)-3-methyl-1H-pyrazol-5(4H)-one underscores its significance in modern drug discovery. Researchers are increasingly exploring its potential in treating complex diseases by designing derivatives that target specific pathological pathways. The compound’s ability to interact with multiple biological systems makes it a valuable tool for understanding disease mechanisms and developing effective treatments.

In conclusion, 1-(3-Aminophenyl)-3-methyl-1H-pyrazol-5(4H)-one (CAS No. 90-32-4) represents a fascinating example of how structural modifications can lead to novel therapeutic agents. Its unique chemical properties and biological relevance make it a cornerstone in pharmaceutical research. As science advances, it is likely that this compound will continue to play a pivotal role in the development of next-generation medications.

• 89-25-8(Edaravone)
• 876-92-6(1-Phenyl-1H-pyrazol-5(4H)-one)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)